DEXCOM INC (DXCM)
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Address
6340 SEQUENCE DRIVE
SAN DIEGO, CA 92121
Founded
1999
Number of Employees
9,600
Website
http://www.dexcom.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s) |
- | - | - | - | - | - | - | - | $557,727 | $188,697 | - | $373,212 |
| Average Price | - | - | - | - | - | - | - | - | $85.03 | $118.12 | - | $91.51 |
| # Shares Purchased | - | - | - | - | - | - | - | - | 6,559,178 | 1,597,500 | - | 4,078,339 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | - | - | -18.9% | -41.6% | - | -24.6% |
| S&P 500 Return to Date | - | - | - | - | - | - | - | - | 37.3% | 31.3% | - | 34.3% |
| Excess Total Return | - | - | - | - | - | - | - | - | -56.1% | -72.9% | - | -58.9% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | - | - | 29% | 9% | - | 26% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at DXCM make a trade.
Creating a free account takes less than one minute